BioRender Icon

Hepatitis B (glycoprotein 2)

Hepatitis B (glycoprotein 2) - Editable icon of Glycoprotein consisting of a thin rounded rectangular base and oval top that is off-centered to the left from the base.
[{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4f06/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4f06/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4f05/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4f05/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4f04/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4f04/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4f03/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4f03/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4f02/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4f02/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4f01/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4f01/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4f00/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4f00/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4eff/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4eff/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4efe/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4efe/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4efd/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4efd/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4efc/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4efc/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4efb/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4efb/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4efa/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4efa/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ef9/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ef9/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ef8/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ef8/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ef7/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ef7/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ef6/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ef6/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ef5/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ef5/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ef4/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ef4/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ef3/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ef3/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ef2/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ef2/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ef1/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ef1/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ef0/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ef0/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4eef/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4eef/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4eee/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4eee/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4eed/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4eed/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4eec/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4eec/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4eeb/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4eeb/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4eea/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4eea/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ee9/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ee9/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ee8/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ee8/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ee7/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ee7/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ee6/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ee6/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ee5/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ee5/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ee4/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ee4/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ee3/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ee3/604fc5c6f37f6000260b4ee1.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/604fc670f37f6000260b4ee2/604fc5c6f37f6000260b4ee1.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/604fc670f37f6000260b4ee2/604fc5c6f37f6000260b4ee1.png"}]
Use This Icon – Free
No credit card required to sign up.

This icon is fully editable in BioRender

  • Add text, shapes, & other icons
  • Search 50,000+ scientifically accurate icons
  • Recolor and rearrange every icon, line, & label
  • Export or share for any use case
Scientist Avatars

Join 4M+ scientists already making publication-ready figures

Go from icons to finished figure – in minutes

  • Search from 50,000+ scientifically accurate, peer-reviewed icons
  • Customize with labels, shapes, and additional icons – everything is completely editable
  • Export or share your figures with collaborators

Not quite the right icon? Discover more.

Search 50,000+ icons across 30+ life-science fields.

search icon
arrow-right
Keywords
hepatitis b,HBV,hepatitis,glycoprotein,surface antigen,australia antigen,HBsAg,serum hepatitis,membrane protein,embdedded protein,pathogen,disease,liver,infection
View More

Try a synonym, or sign up to request an icon from the app.

Image types

Hepatitis B (glycoprotein 2) icon JPEG

Hepatitis B (glycoprotein 2) icon PNG

Hepatitis B (glycoprotein 2) icon SVG

Hepatitis B (glycoprotein 2) icon GIF

Biorender Icon FAQs

How are scientists using the Hepatitis B (glycoprotein 2) icon in their work?

BioRender users often use the Hepatitis B (glycoprotein 2) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Species.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Hepatitis B (glycoprotein 2) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Hepatitis B (glycoprotein 2) icon customizable in BioRender?

Most icons in BioRender, including the Hepatitis B (glycoprotein 2) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Hepatitis B (glycoprotein 2) icon for publication or presentations?

Yes, figures containing the Hepatitis B (glycoprotein 2) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Hepatitis B (glycoprotein 2) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Hepatitis B (glycoprotein 2) icon — especially those focused on Species. You can search BioRender’s template library or add this icon manually to any canvas.

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Hepatitis B (glycoprotein 2) icon along with our library of more than 30,000 life science icons.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon